Gufic Biosciences Limited (GUFICBIO) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE742B01025
Key metrics
- Market Cap
- ₹4,400 Cr
- P/E Ratio
- 59.86
- EPS
- 7.64
- Book Value
- 66.31
- P/B Ratio
- 6.33
- ROE
- 9.66%
- ROCE
- 11.27%
- Debt / Equity
- 0.61
- Net Margin
- 7.9%
- Revenue Growth
- 9%
- Profit Growth
- -7.8%
- Dividend Yield
- 0.02%
- 52W High
- ₹453.95
- 52W Low
- ₹268.00
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Gufic Biosciences Limited
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 1,607
- Promoter Holding
- 77.5%
The full Gufic Biosciences Limited analysis
Create a free account to open the complete GUFICBIO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.